ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,387Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 117

$695K Total Retail Price of All Prescriptions

Rank: 19 out of 117

331 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 331 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

31% of this provider’s 331 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,195 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
HYDROCODONE-ACETAMINOPHEN 580 498 S3 1 7
FUROSEMIDE 438 438 2 3
LEVOTHYROXINE SODIUM 389 366 3 2
POTASSIUM CHLORIDE 309 279 4 17
AMLODIPINE BESYLATE 308 296 5 5
SIMVASTATIN 306 278 6 1
LISINOPRIL 295 269 7 4
METFORMIN HCL 291 234 8 11
OMEPRAZOLE 287 252 9 6
METOPROLOL TARTRATE 265 265 10 8
WARFARIN SODIUM 199 193 11 9
ATENOLOL 198 198 12 20
ATORVASTATIN CALCIUM 186 179 13 15
METOPROLOL SUCCINATE 168 159 14 12
LANTUS 148 138 15 43
MIRTAZAPINE 129 105 16 25
NEXIUM 129 116 16 62
DONEPEZIL HCL 121 116 18 10
CLOPIDOGREL 120 120 19 30
CITALOPRAM HBR 114 113 20 19
TRAMADOL HCL 113 95 21 18
NAMENDA 107 107 22 14
HYDROCHLOROTHIAZIDE 107 91 22 13
RANITIDINE HCL 101 99 24 58
JANUVIA 100 97 25 64
QUETIAPINE FUMARATE 97 60 26 36
GLIMEPIRIDE 89 81 27 69
TRIAMTERENE-HCTZ 87 83 28 74
SPIRIVA 86 60 29 60
PLAVIX 82 79 30 47
GLIPIZIDE 82 70 30 37
SERTRALINE HCL 82 61 30 22
CYMBALTA 79 79 33 59
CARBIDOPA-LEVODOPA 78 78 34 45
HYDRALAZINE HCL 73 67 35 54
TRAZODONE HCL 72 72 36 44
SPIRONOLACTONE 70 64 37 53
FENTANYL 69 61 S2 38 41
CARVEDILOL 69 46 38 24
ADVAIR DISKUS 67 45 40 51
BENICAR HCT 66 66 41 202
CYCLOBENZAPRINE HCL 66 44 R 41 133
OXYBUTYNIN CHLORIDE ER 65 65 43 77
ALENDRONATE SODIUM 63 50 44 21
GABAPENTIN 62 48 45 16
BYSTOLIC 60 60 46 94
PANTOPRAZOLE SODIUM 60 60 46 26
SINGULAIR 60 52 46 116
DIGOXIN 60 60 46 35
AZITHROMYCIN 58 49 50 57
BUSPIRONE HCL 58 34 50 131
ZOLPIDEM TARTRATE 55 37 52 27
CRESTOR 54 54 53 50
PREDNISONE 52 52 54 49
PHENYTOIN SODIUM EXTENDED 52 40 54 137
OXYBUTYNIN CHLORIDE 52 52 54 208
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.